Log In
BCIQ
Print this Print this
 

KD025 (formerly SLx-2119)

  Manage Alerts
Collapse Summary General Information
Company Kadmon Holdings Inc.
DescriptionOral selective inhibitor of Rho-associated coiled-coil containing protein kinase 2 (ROCK2)
Molecular Target Rho-associated coiled-coil containing protein kinase 2 (ROCK2)
Mechanism of ActionRho-associated coiled-coil containing protein kinase (ROCK) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/02/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today